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Background. System x−c is a heterodimeric transporter, com-
prised of a light chain, xCT, and heavy chain, 4F2hc, which
mediates the sodium-independent exchange of cystine and glu-
tamate at the plasma membrane. In the current study we tested
the hypothesis that stable transfection of Madin-Darby canine
kidney (MDCK) cells with human xCT and 4F2hc results in the
expression of functional system x−c .
Methods. MDCK cells were transfected stably with human
clones for xCT and 4F2hc. Analyses of time- and temperature-
dependence, saturation kinetics, and substrate specificity of L-
cystine and L-glutamate transport were carried out in control
and xCT-4F2hc-transfected MDCK cells. We also measured the
uptake of L-cystine in Xenopus oocytes expressing human xCT
and/or 4F2hc or xCT and/or rBAT (a heavy chain homologous
to 4F2hc).
Results. All of the different sets of data revealed that
transport of L-cystine and L-glutamate increased significantly
(twofold to threefold) in the MDCK cells subsequent to trans-
fection with xCT-4F2hc. Moreover, uptake of L-cystine also in-
creased (about tenfold) in Xenopus oocytes expressing hxCT
and h4F2hc. Biochemical analyses of L-cystine uptake in oocytes
verified our findings in the transfected MDCK cells. Interest-
ingly, in oocytes injected with rBAT with or without xCT, uptake
of L-cystine was significantly greater than that in water-injected
oocytes.
Conclusion. Our findings indicate that stable transfection of
MDCK cells with xCT and 4F2hc results in a cell-line expressing
a functional system x−c transporter that can utilize L-cystine and
L-glutamate as substrates. This study apparently represents the
first stable transfection of a mammalian cell line with system
x−c .
System x−c (designated as such by Makowske and
Christensen, [1]) is a sodium (Na+)-independent cystine/
glutamate transporter that has been found in numerous
types of mammalian cells [1–6]. This transporter medi-
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ates the electroneutral exchange of cystine (which is in a
partially deproteinated form having a net charge of –1)
and glutamate at the plasma membrane, typically pro-
moting the cellular uptake of cystine through the efflux
of glutamate.
Although a number of studies have characterized the
transport activity of this system, the molecular iden-
tities of the components of system x−c were identified
only recently. Expression cloning from mouse peritoneal
macrophages revealed that there are two distinct pro-
teins that, when expressed together in Xenopus oocytes,
induced transport activity similar to that described for
system x−c in native cells [7]. While one of these proteins
was identified as the heavy chain of the 4F2 cell surface
antigen (4F2hc), the other, designated as xCT (system x−c
transporter-related protein) was a novel protein [7]. The
light chain, xCT, was described as a protein containing 502
amino acids with 12 putative transmembrane domains [7].
Since its initial identification, xCT has been cloned from
human fibroblasts [8], human glial cells [9], human retinal
pigment epithelium [10], and a human teratocarcinoma
cell line, NT2 [11]. As a heterodimeric transporter, sys-
tem x−c requires both, 4F2hc and xCT, for its activity, al-
though xCT appears to be the functional transport unit
of this carrier protein.
Under normal physiologic conditions, system x−c is ex-
pressed ubiquitously at low levels in mammalian cells
[12]. However, under conditions of oxidative stress,
the transport activity of this carrier appears to be up-
regulated [9, 10, 13–20], possibly via an amino acid re-
sponse element [21]. As a result of this up-regulation, an
increased number of cystine molecules could be trans-
ported into the cells, which, in turn, would provide
(after intracellular reduction) an increased number of
molecules of cysteine (the rate-limiting substrate) for glu-
tathione (GSH) synthesis [3, 22]. It should be mentioned
that because of the oxidative nature of blood and extra-
cellular compartments, cysteine is supplied primarily to
most cells in its oxidized form, cystine.
System x−c also plays an important role in the main-
tenance of other normal cellular homeostatic processes
[23, 24]. Given the importance of amino acid transport
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and GSH biosynthesis in renal tubular epithelial cells, it
is crucial that a thorough and complete understanding of
the mechanisms involved in the transport and metabolism
of cysteine and cystine be obtained. In renal tubular ep-
ithelial cells, a number of cystine transporters have been
identified, including systems b0,+, B0,+, and L [24]. In ad-
dition, system x−c has been identified in the mouse kidney
[7] by Northern blot analyses and in cultured proximal
tubular cells (LLC-PK1) by functional analyses [5].
The role of system x−c in the transport of cystine, glu-
tamate, and other amino acids across the plasma mem-
branes of renal epithelial cells has not been well charac-
terized. One of the principal aims of the present study
was to determine the mechanistic role of system x−c in
the transport of L-cystine, L-cysteine and other poten-
tial substrates in a line of renal epithelial cells [Madin-
Darby canine kidney (MDCK)] transfected stably with
both subunits of this transporter. MDCK cells were cho-
sen for this study because they are derived from the distal
nephron, and, thus, do not express the same endogenous
cystine transporters (e.g., system b0,+) that are expressed
on the luminal plasma membrane of proximal tubular
cells. Moreover, MDCK cells have been transfected suc-
cessfully with other amino acid transporters and have
proven to be reliable models for the study of amino acid
transport [25–28]. In the present study, we have success-
fully created a line of MDCK cells that stably express
functional forms of human xCT and human 4F2hc. Us-
ing this cell line, we tested the hypothesis that system x−c
mediates the transport of L-cystine and L-glutamate.
We also utilized oocytes from Xenopus laevis, microin-
jected with the cRNA encoding the subunits of system x−c ,
to study L-cystine and L-glutamate transport. Xenopus
oocytes represent a nonmammalian model that has been
used to study a number of transport systems, including
system x−c [7, 29]. Since they have very few endogenous
transporters, oocytes provide a good model in which to
study a selected transporter. In the present study, we used
this model as an additional means to test the hypothesis
that system x−c mediates the transport of L-cystine and
L-glutamate. The results of these experiments were also
used to validate the results of the experiments carried out
in the transfected MDCK cells.
The results from the present study indicate that MDCK
cells transfected stably with hxCT and h4F2hc express
a functional system x−c transporter that mediates Na
+-
independent uptake of L-cystine and L-glutamate. Data
obtained from experiments in Xenopus oocytes support
this conclusion. Together, these findings indicate that the
MDCK cells transfected stably with xCT-4F2hc are a reli-
able model in which to study the activity of system x−c . To
our knowledge, this study represents the first time that
human xCT and human 4F2hc have been transfected
stably and studied in a mammalian renal epithelial cell
line.
METHODS
Tissue culture
MDCK type II cells were kindly provided by Dr. John
Pritchard at the National Institute of Environmental
Health Sciences (Research Triangle Park, NC, USA).
Cells were cultured in Dulbecco’s modified Eagle’s
medium (Mediatech, Herndon, VA, USA) supplemented
with 10% fetal bovine serum (FBS) (Atlanta Biologicals,
Norcross, GA, USA), 100 U/mL penicillin, 100 lg/mL
streptomycin, and 1% essential amino acids (Invitrogen,
Carlsbad, CA, USA). Cells were passaged by dissocia-
tion in 0.25% trypsin (Invitrogen)/0.5 mmol/L ethylene-
diaminetetraacetic acid (EDTA) in phosphate-buffered
saline (PBS). Cultures were maintained at 37◦C in a hu-
midified atmosphere of 5% CO2 and 95% air.
Stable transfection of MDCK cells
The cDNA transcripts for human xCT (hxCT) and hu-
man 4F2hc (h4F2hc) were kindly provided by Dr. Vadivel
Ganapathy (Medical College of Georgia, Augusta, GA,
USA). The cDNA for hxCT or h4F2hc was subcloned
into the EcoRI/NotI sites of the pcDNA 3.1(+) vector
(Invitrogen) that confers resistance to zeocin or geneticin
(G418), respectively.
Two days prior to transfection, cells were seeded in
24-well plates at a density of 6 × 104 cells per well.
Cells were transfected, according to the manufacturer’s
instructions, with Lipofectamine 2000 (Invitrogen). Ini-
tially, cells were transfected with hxCT, and stable trans-
fectants were selected by culturing cells for 3 weeks in
800 lg/mL zeocin. Following selection, the concentration
of zeocin was reduced to 500 lg/mL and the cells were
transfected with h4F2hc. Stable transfectants possessing
both subunits (xCT-4F2hc transfectants) were selected by
culturing cells for 3 weeks in the presence of 500 lg/mL
zeocin and 800 lg/mL geneticin. The concentration of
geneticin was then reduced to 500 lg/mL. As a nega-
tive control, some cells were transfected with each of the
pcDNA 3.1(+) vectors (without cDNA inserts) and were
selected as described. These cells are hereafter referred
to as control cells.
Reverse transcriptase-polymerase chain reaction
(RT-PCR)
RT-PCR analyses were carried out to confirm the pres-
ence of hxCT and h4F2hc in the xCT-4F2hc transfectants.
Total RNA was isolated from the xCT-4F2hc transfec-
tants and control cells using Trizol (Invitrogen) accord-
ing to the manufacturer’s directions. The primers specific
for hxCT and h4F2hc have been described previously
[10]. As a positive control, the expression of canine
glyceraldehyde-3-phosphate dehydrogenase (cGAPDH)
was analyzed. The forward primer corresponded to bases
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335-356 (5′-GCG GGG CCA AGA GGG TCA TCA T-
3′) while the reverse primer corresponded to bases 749-
727 (5′-GCT TTC TCC AGG CGG CAG GTC AG-3′).
Evaluation of transport
In the current study, we analyzed the uptake of radio-
labeled L-cystine and L-glutamate in order to thoroughly
characterize the activity of system x−c in control cells and
xCT-4F2hc transfectants. Since system x−c is an exchanger
of cystine and glutamate, the activity of this carrier can
be monitored by measuring the uptake of radiolabeled L-
cystine or L-glutamate. Indeed, previous studies in retinal
pigment epithelial cells have utilized radiolabeled gluta-
mate to measure successfully the activity of system x−c
[10, 14]. It should be noted that, for the purpose of the
current study, we assumed that extracellular L-cystine or
L-glutamate could exchange for intracellular L-glutamate
or L-cystine, respectively.
Uptake measurements were performed as described
previously [10, 14, 26, 27]. Briefly, culture media was aspi-
rated from wells and cells were washed with warm uptake
buffer lacking Na+ [25 mmol/L 4-(2-hydroxyethyl)-1-
piperazineethansulfonic acid (Hepes)/Tris, 140 mmol/L
N-methyl-D-glucamine chloride, 5.4 mmol/L KCl,
1.8 mmol/L CaCl2, 0.8 mmol/L MgSO4, and 5 mmol/L
glucose, pH 7.5]. Uptake was initiated by adding 250 lL
of uptake buffer containing [35S]-L-cystine (0.6 mCi/mg;
0.125 lCi/well) or [3H]-L-glutamic acid (33.3 mCi/mg;
0.0625 lCi/well) (Amersham Biosciences, Piscataway, NJ,
USA). After incubation for the desired time, the radi-
olabeled compounds were removed and the cells were
washed twice with ice-cold uptake buffer. Cells were then
solubilized with 1% sodium dodecyl sulfate (SDS) in
0.2 N NaOH and the cellular lysate was added to 5 mL of
Opti-Fluor scintillation cocktail (Perkin Elmer, Shelton,
CT, USA). The radioactivity contained therein was deter-
mined by counting samples in a Beckman LS6500 scin-
tillation counter (Beckman Instruments, Fullerton, CA,
USA).
Microinjection of Xenopus laevis oocytes
Ovaries were isolated from sexually mature, female
Xenopus laevis (Xenopus One, Ann Arbor, MI, USA)
and defolliculated as described previously [30]. Briefly,
this process employs digestion of connective tissue with
1 mg/mL collagenase A (Roche Molecular Biochemi-
cals, Indianapolis, IN, USA) followed by incubation in
100 mmol/L K2HPO4. Following isolation, the oocytes
were placed in Oocyte Ringer’s 2 (OR-2) (82.5 mmol/L
NaCl, 2.5 mmol/L KCl, 1 mmol/L Na2HPO4, 3 mmol/L
NaOH, 1 mmol/L CaCl2, 1 mmol/L MgCl2, 1 mmol/L Na-
pyruvate, and 5 mmol/L Hepes, pH 7.6) supplemented
with 5% horse serum (Atlanta Biologicals) and 50 lg/mL
gentamycin sulfate (Invitrogen) and stored overnight in
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Fig. 1. Photographic presentation of reverse transcription-polymerase
chain reaction (RT-PCR) analyses for human xCT(hxCT) and canine
xCT (cxCT), human 4F2hc (h4F2hc) and canine 4F2hc (c4F2hc), and
canine glyceraldehyde-3-phosphate dehydrogenase (cGAPDH) in con-
trol and xCT-4F2hc–transfected Madin-Darby canine kidney (MDCK)
cells. The expected sizes of the RT-PCR products, as predicted from the
positions of the primers, were 724 bp for hxCT, 603 bp for h4F2hc, and
415 bp for cGAPDH.
a shaking incubator at 18◦C. Stage IV and V oocytes were
then microinjected with 23 nL of either molecular biol-
ogy grade water or capped RNA encoding hxCT, h4F2hc,
or hrBAT at a concentration of 1.24 lg/lL.
Transport experiments with the oocytes were con-
ducted three days following injection. Prior to use, the
oocytes were separated into groups of ten in 24-well plates
and were washed with 1 mL of uptake buffer. Then,
350 lL of uptake buffer containing 5 lmol/L L-cystine
(containing [35S]-L-cystine) were added to each well and
incubated for 30 min at room temperature. Following in-
cubation, oocytes were rinsed twice with 1 mL of ice-cold
uptake buffer. Oocytes were then lysed in 0.5 mL of 1%
SDS/0.2 N NaOH. After complete lysis, the radioactiv-
ity of the samples was determined by liquid scintillation
spectroscopy as described above.
Data analyses
All experiments were performed in triplicate or qua-
druplicate and were repeated at least twice for confir-
mation. Data for each parameter assessed (N = 3 or 4)
were first analyzed using a two-way or three-way anal-
ysis of variance (ANOVA). Tukey’s multiple compari-
son procedure was used to assess differences among the
means. A P value of < 0.05 was considered statistically
significant.
RESULTS
RT-PCR
The presence of mRNA transcripts encoding hxCT and
h4F2hc was confirmed using RT-PCR analyses (Fig. 1). A
724 bp fragment was obtained for hxCT while a 603 bp
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Fig. 2. Uptake of [35S]-L-cystine or [3H]-L-
glutamate in control and xCT-4F2hc–
transfected Madin-Darby canine kidney
(MDCK) cells. Cells were exposed to 5 lmol/
L [35S]-L-cystine (A) or [3H]-L-glutamate
(B) at 37◦C for time periods ranging from
5 to 90 minutes. Samples were taken for
determinations at indicated times. Data are
presented as mean ± SE for four samples.
Each experiment was performed at least
twice for the purpose of validation. ∗Signifi-
cantly different (P < 0.05) from the mean
for the corresponding group of control cells;
+ Significantly different from the mean for
the same cell type at the initial time point;
++, +++, ++++, +++++, or ++++++
Significantly different from the mean for the
same cell type at each of the preceding time
points.
fragment was obtained for h4F2hc. Transcripts encoding
these proteins were identified in both the control cells and
the xCT-4F2hc transfectants; however, the intensity of the
bands was greater in the transfectants. A 415 bp fragment
was observed for cGAPDH. There was no detectable dif-
ference in the expression of cGAPDH between the con-
trol cells and the xCT-4F2hc transfectants.
Characterization of system x−c activity in MDCK
transfectants
Time course analyses were carried out in control and
xCT-4F2hc–transfected MDCK cells. The uptake of [35S]-
L-cystine (Fig. 2A) or [3H]-L-glutamate (Fig. 2B) in-
creased in both types of cells over the course of 90
minutes. However, the uptake of each compound was
significantly greater in the xCT-4F2hc transfectants than
in the control cells at nearly every time examined.
The Michaelis-Menten kinetics of L-cystine (Fig. 3A)
or L-glutamate (Fig. 3B) transport was also measured
in control and xCT-4F2hc–transfected cells. As with the
time course results, the uptake of [35S]-L-cystine or [3H]-
L-glutamate was significantly greater in the transfec-
tants than in the control cells at almost every concen-
tration studied. The estimated maximum velocity (Vmax)
of [35S]-L-cystine transport was 589.9 ± 26 pmol × mg
protein−1 × min−1 in the xCT-4F2hc transfectants and
322.5 ± 30.1 pmol × mg protein−1 × min−1 in the
control cells. The Michaelis-Menten constant (Km) was
calculated to be 121.0 ± 17.8 lmol/L for the xCT-4F2hc
transfectants and 164.2 ± 47.5 lmol/L for the control
cells. Regarding the uptake of [3H]-L-glutamate, the Vmax
was 2.06 ± 0.18 nmol × mg protein−1 × min−1 in the
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Fig. 3. Saturation kinetics for the transport
of [35S]-L-cystine or [3H]-L-glutamate in
control and xCT-4F2hc–transfected Madin-
Darby canine kidney (MDCK) cells. Cells
were incubated for 15 minutes at 37◦C
with 5 lmol/L [35S]-L-cystine (A) or [3H]-
L-glutamate (B) in the presence of unla-
beled L-cystine or L-glutamate, respectively.
Each inset represents an Eadie-Hofstee plot
of the data. Results are presented as mean ±
SE for four samples. Each experiment was
performed twice for the purpose of validation.
∗Significantly different (P < 0.05) from the
mean for the corresponding group of control
cells; + Significantly different from the mean
for the same cell type at the initial concentra-
tion; ++ or +++ Significantly different from
the mean for the same cell type at each of the
preceding concentrations.
xCT-4F2hc transfectants and 0.68 ± 0.05 nmol × mg pro-
tein−1 × min−1 in the control cells. The Km was estimated
to be 0.50 ± 0.09 mmol/L in the transfectants and 0.76 ±
0.11 mmol/L in the control cells.
The temperature dependence of the activity of sys-
tem x−c was measured by analyzing the saturation ki-
netics for the uptake of [35S]-L-cystine (Fig. 4A) or
[3H]-L-glutamate (Fig. 4B) in control MDCK cells and
xCT-4F2hc transfectants at 4◦C and 37◦C. The uptake of
either substrate at 37◦C was significantly greater in the
transfectants than in the corresponding group of control
cells at every concentration studied. When the experi-
mental temperature was maintained at 4◦C, transport ac-
tivity was negligible in both cell types. Additionally, there
were no significant differences in the accumulation of cys-
tine or glutamate between corresponding groups of trans-
fected and control cells.
Figure 5 shows substrate-specificity analyses for the
transport of L-cystine (Fig. 5A) or L-glutamate (Fig. 5B),
in the absence of Na+, in control cells and xCT-
4F2hc transfectants. The uptake of [35S]-L-cystine in
the transfectants was reduced significantly by the pres-
ence of unlabeled L-cysteine, L-cystine, DL-homocysteine,
L-glutamate, L-serine, L-leucine, L-phenylalanine, L-
proline, L-alanine, and L-aspartate. With the exception
of cells exposed to L-cystine, L-cysteine, L-glutamate,
or L-lysine, there were no significant differences in
the uptake of L-cystine among the groups of control
658 Bridges and Zalups et al: Characterization of x−c in MDCK cells
800
Up
ta
ke
 o
f [3
5 S
]-L
-
Cy
st
in
e,
pm
ol
 x
 m
g 
pr
ot
ei
n−
1  
x 
m
in
−
1
600
400
200
0
0 200 400 600 800 1000
xCT-4F2hc transfectants - 37°C
xCT-4F2hc transfectants - 4°C
Wild-type MDCK II cells - 37°C
Wild-type MDCK II
cells - 4°C
*
*
*
*
*
*
*
*
A
L-Cystine, µmol/L
Up
ta
ke
 o
f [3
H
]-L
-
G
lu
ta
m
at
e,
pm
ol
 x
 m
g 
pr
ot
ei
n−
1  
x 
m
in
−
1
*
*
*
*
*
*
*
*
B
350
300
100
150
200
250
50
0
0 200 400 600 800 1000
L-Glutamate, µmol/L
Fig. 4. Effect of temperature on the up-
take of cystine or glutamate in control and
xCT-4F2hc–transfected Madin-Darby canine
kidney (MDCK) cells. Cells were exposed
to 5 lmol/L [35S]-L-cystine (A) or [3H]-L-
glutamate (B) for 15 minutes at 37◦C or 4◦C
in the presence of unlabeled L-cystine or L-
glutamate, respectively. Data are presented
as mean ± SE for four samples. Each exper-
iment was performed at least twice for the
purpose of validation. ∗Significantly different
(P < 0.05) from the mean for the correspond-
ing group of control cells.
cells. The pattern of amino acid inhibition of [3H]-L-
glutamate uptake was similar to that of L-cystine. The
transport of glutamate was reduced significantly by L-
cysteine, L-cystine, L-glutamate, L-serine, L-leucine, L-
phenylalanine, L-proline, L-alanine, and L-aspartate. In
the corresponding control cells, only L-cysteine, L-cystine,
and L-glutamate inhibited significantly the uptake of
L-glutamate.
Characterization of system x−c activity in Xenopus laevis
oocytes
Time course analyses were carried out in Xenopus
oocytes injected simultaneously with RNA encoding
hxCT and h4F2hc. A fifteen-fold increase in the uptake
of [35S]-L-cystine (Fig. 6) was observed in the oocytes in-
jected with hxCT and h4F2hc relative to that in water-
injected controls.
In addition, analyses of the saturation kinetics for the
uptake of L-cystine (Fig. 7) were carried out in water-
injected and hxCT-h4F2hc–injected oocytes. At every
concentration examined, the uptake of [35S]-L-cystine
was significantly greater in the hxCT-h4F2hc–injected
oocytes than in the water-injected oocytes. The Vmax for
the uptake in the hxCT-h4F2hc–injected oocytes was cal-
culated to be 293.2 ± 39.3 pmol × mg protein−1 × min−1
while the Km was estimated to be 120.9 ± 51.8 lmol/L.
Sodium-independent, substrate-specificity analyses of
L-cystine uptake (Fig. 8) were also carried out in
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Fig. 5. Substrate specificity analyses of the
sodium-independent transport of [35S]-L-
cystine or [3H]-L-glutamate in control and
xCT-4F2hc–transfected Madin-Darby canine
kidney cells. Cells were incubated for 15 min-
utes at 37◦C with 5 lmol/L [35S]-L-cystine (A)
or [3H]-L-glutamate (B) in the presence of
various unlabeled amino acids (3 mmol/L)
(unlabeled L-cystine and DL-homocystine,
1 mmol/L). Data are presented as mean ±
SE for four samples. Each experiment was
performed at least twice for the purpose of
validation. ∗Significantly different (P < 0.05)
from the mean for the corresponding group
of control cells; +Significantly different from
the mean for the control group of the corre-
sponding cell type.
water- and hxCT-h4F2hc–injected oocytes. These anal-
yses demonstrated that the amino acids, L-cysteine,
L-cystine, DL-homocysteine, L-glutamate, L-leucine, L-
alanine, and L-aspartate were able to inhibit significantly
the uptake of [35S]-L-cystine in the hxCT-h4F2hc–injected
oocytes, while there was no significant inhibition in cor-
responding water-injected controls.
As a negative control, some oocytes were injected with
hxCT or h4F2hc alone (Fig. 9A). The uptake of [35S]-L-
cystine in these groups of oocytes was not significantly
different from that in corresponding groups of oocytes
injected with water. Under certain conditions (possibly
pathologic), the heavy chain, rBAT, may associate with
a light chain subunit other than its normal counterpart,
b0,+AT. To test this possibility, the uptake of [35S]-L-
cystine was measured in oocytes injected simultaneously
with hxCT and hrBAT or with hrBAT alone (Fig. 9A).
Simultaneous injection of hxCT and hrBAT resulted in
a ninefold increase in the uptake of cystine compared
with that in water-injected controls. Interestingly, the
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Fig. 6. Uptake of cystine in Xenopus oocytes injected simultaneously
with human xCT (hxCT) and human 4F2hc (h4F2hc) or water. Oocytes
were exposed to 5 lmol/L [35S]-L-cystine at room temperature for time
periods ranging from 5 to 60 minutes. Samples were taken for esti-
mation at indicated time points. Data are presented as mean ± SE of
three samples, with each sample obtained from 10 oocytes per well.
Each experiment was also performed at least twice for the purpose of
validation. ∗Significantly different (P < 0.05) from the mean for the
corresponding group of water-injected oocytes; +Significantly differ-
ent from the mean for the same set of oocytes at the initial time point;
++ or +++Significantly different from the mean for the same set of
oocytes at each of the preceding time points.
uptake of [35S]-L-cystine in oocytes expressing hrBAT
only was approximately sevenfold greater than that of
water-injected controls.
In order to determine the possible transport systems
that mediate the uptake of L-cystine in oocytes injected
with either xCT and 4F2hc, xCT and rBAT, rBAT alone,
or water, the transport of [35S]-L-cystine was measured
in the presence of L-glutamate or L-arginine (Fig. 9B).
L-glutamate, which is a characteristic substrate of system
x−c inhibited significantly the uptake of [
35S]-L-cystine in
the oocytes injected with xCT and 4F2hc, but did not in-
hibit this uptake in other groups of oocytes. Alternatively,
L-arginine, which is a substrate of system b0,+, inhibited
significantly the uptake of [35S]-L-cystine in oocytes in-
jected with xCT and rBAT or rBAT alone, but had no
effect on this uptake in oocytes injected with xCT and
4F2hc.
DISCUSSION
Cystine is an amino acid essential for the maintenance
of numerous vital cellular activities. As a result, various
organs in the body attempt to conserve this amino acid
by means of absorptive transport. In the kidneys, the cys-
tine that is ultra-filtered at the glomeruli is reclaimed by
absorptive transport primarily along the pars convoluta
and pars recta of the proximal tubule. Genetic defects
affecting the luminal absorption of cystine in the prox-
imal tubules of humans is of clinical importance, inas-
much as cystinuria is induced, which increases the risk of
intrarenal development of cystine calculi [31]. Accord-
ingly, the primary focus of most studies on renal cystine
transport has been on the luminal handling of this amino
acid. Not surprisingly, though, cystine is also taken up
from the peritubular capillaries at the basolateral plasma
membrane. This probably occurs in all of the epithelial
cells lining the nephron and collecting duct, since this
form of uptake likely represents the means by which these
epithelial cells can obtain cystine for nutritive and home-
ostatic purposes [24].
One potential mechanism involved in the basolateral
transport of cystine is the cystine/glutamate transporter,
system x−c . This transporter has been studied in various
types of cells, yet little is known about its activity in the ep-
ithelial cells lining the various segments of the nephron.
Therefore, one of the aims of the present study was to
characterize the activity of this carrier in a line of renal
epithelial cells. MDCK cells were chosen for this study
because they are derived from the distal nephron, where
there is little, to no, absorptive (luminal) transport of
cystine. We tested the hypothesis that cystine and glu-
tamate are high affinity substrates of system x−c when this
transporter is expressed in MDCK cells transfected sta-
bly with both subunits of this carrier. This study is novel
in that we have characterized the uptake of L-cystine and
L-glutamate in an epithelial cell-line that has been ge-
netically manipulated to overexpress system x−c . It is im-
portant to note that many of the previous studies of this
carrier were carried out in cell lines that expressed this,
and other, cystine transporter(s) natively. In the present
study, we utilized a renal epithelial cell line derived
from the distal nephron (MDCK cells). These epithelial
cells express relatively fewer native cystine transporters
than the epithelial cells lining the proximal tubule. Sta-
ble transfection of these cells with system x−c provides a
means to study the activity of this carrier by measuring
differences in L-cystine transport between transfectants
and control cells. To our knowledge, we are the first to
characterize the uptake of L-cystine and L-glutamate in
a mammalian epithelial cell line transfected stably with
system x−c .
RT-PCR analyses of xCT and 4F2hc in the control and
xCT-4F2hc–transfected MDCK cells indicate that system
x−c is overexpressed in the xCT-4F2hc transfectants. Al-
though transcripts encoding xCT and 4F2hc were identi-
fied in the control cells, the overexpression resulting from
the stable transfection of xCT and 4F2hc allowed us to
study selectively the activity of system x−c in this line of
cells. Since the only apparent difference between the xCT-
4F2hc transfectants and the control cells is the presence
of additional transcripts encoding xCT and 4F2hc, differ-
ences in the transport of L-cystine and L-glutamate can
be attributed to the activity of system x−c . Furthermore,
overexpression of system x−c in MDCK cells results in
the probable localization of this carrier in both luminal
Bridges and Zalups et al: Characterization of x−c in MDCK cells 661
Up
ta
ke
 o
f [3
5 S
]-L
-
Cy
st
in
e,
pm
ol
 x
 m
g 
pr
ot
ei
n−
1  
x 
m
in
−
1
300
200
100
0
0 200 400
L-Cystine, µmol/L
600 800
hxCT + h4F2hc
Water-injected
350
Ve
lo
ci
ty
Velocity/[substrate]
300
250
200
150
100
50
0
0.0 0.5 1.0 1.5 2.0 2.5
*
+
+
*++
*+++
*++++
*+
*
Fig. 7. Saturation kinetics of cystine uptake
in Xenopus oocytes injected simultaneously
with human xCT (hxCT) and human 4F2hc
(h4F2hc) or water. Oocytes were exposed
to 5 lmol/L [35S]-L-cystine for 30 minutes
at room temperature in the presence of un-
labeled cystine (inset, Eadie-Hofstee plot).
Data are presented as mean ± SE of three
samples, with each sample obtained from 10
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validation. ∗Significantly different (P < 0.05)
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of water-injected oocytes; + Significantly dif-
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+++ Significantly different from the mean for
the same set of oocytes at each of the preced-
ing concentrations.
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and basolateral plasma membranes, and thus, allows us
access to a transporter that is localized normally to the
basolateral plasma membrane of most epithelial cells.
Time course analyses revealed that the rate of uptake of
L-cystine and L-glutamate was at least twofold greater in
the xCT-4F2hc transfectants than in control cells. Anal-
yses of the saturation kinetics for the transport of cys-
tine also showed a twofold or greater increase in uptake
in the transfectants compared with that in control cells.
Experiments measuring the uptake of L-cystine in Xeno-
pus oocytes validated these findings. The apparent Km
(a measure of substrate affinity) for L-cystine transport in
the transfectants (121.0 ± 17.8 lmol/L) (Fig. 2) was nearly
identical to that calculated for the uptake of L-cystine in
Xenopus oocytes (120.9 ± 51.8 lmol/L) (Fig. 8). More-
over, these values were similar to those obtained in other
types of nontransfected cells [5, 32].
It is important to note that the apparent Km for the
transport of L-cystine was lower in the xCT-4F2hc trans-
fectants (121.0 ± 17.8 lmol/L) than in control cells
(164.2 ± 47.5 lmol/L). This was also true of the Km for L-
glutamate transport (0.76 ± 0.11 mmol/L for control cells
and 0.50 ± 0.09 mmol/L for the transfectants). These find-
ings were somewhat surprising since MDCK cells express
system x−c endogenously. We originally anticipated that
the Km would be similar in both types of cells since the
same transport system is ostensibly involved in the uptake
of L-cystine. A possible explanation for this shift in affinity
is that, in control cells, a larger fraction of L-cystine up-
take is mediated by endogenous transporters, other than
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Fig. 9. Uptake of L-cystine in Xenopus
oocytes injected with various cDNA con-
structs. (A) Oocytes were injected with ei-
ther water, human xCT (hxCT), human 4F2hc
(h4F2hc), human rBAT (hrBAT) or simul-
taneously with hxCT and h4F2hc or hxCT
and hrBAT and exposed to 5 lmol/L [35S]-L-
cystine for 30 minutes at room temperature.
(B) Oocytes were injected with either wa-
ter, hxCT, and h4F2hc, or hxCT and hrBAT
and were exposed to 5 lmol/L [35S]-L-cystine
for 30 minutes at room temperature in the
presence of 3 mmol/L unlabeled arginine or
glutamate. Data are presented as mean ±
SE of three samples, with each sample ob-
tained from 10 oocytes per well. Each ex-
periment was also performed at least twice
for the purpose of validation. ∗Significantly
different (P < 0.05) from the mean for the
water-injected oocytes; + Significantly dif-
ferent from all other groups of oocytes;
++ Significantly different from the mean for
the control oocytes injected with the same
RNA transcripts.
system x−c . The affinity of these transporters for cystine
would likely be lower than that of system x−c . Transfection
of xCT and 4F2hc may have permitted a greater percent-
age of the total pool of transported L-cystine to be taken
up by system x−c and less by endogenous transporters. This
would have resulted in a lower Km (i.e., higher affinity)
for the transport of L-cystine in the transfectants.
In addition to the aforementioned time course and
kinetic analyses, data from substrate specificity experi-
ments provide substantive evidence supporting the relia-
bility of the xCT-4F2hc transfectants as models in which
to study the activity of system x−c . Compounds (e.g., L-
cystine, L-glutamate, L-aspartate, L-serine, L-alanine) that
have been identified as substrates of system x−c [2–4,
6, 8–10, 32] inhibited the transport of L-cystine and L-
glutamate; whereas compounds that are not substrates
of this carrier did not affect the uptake of these amino
acids. This pattern of amino acid inhibition was also ob-
served in experiments utilizing Xenopus oocytes, which
validates the transport data in the MDCK cells. In ad-
dition, the pattern of amino acid inhibition of L-cystine
transport remained the same in the presence and absence
of Na+ ions, despite the fact that transport activity was
greater in the presence of Na+ (data not shown). The in-
creased rate of uptake in the presence of Na+ is likely
due to the activities of Na+-dependent amino acid trans-
porters, such as systems A, or ASC, all of which have been
identified in MDCK cells [33].
Data from the current study also indicate that both xCT
and 4F2hc are required for system x−c to function prop-
erly. Indeed, our data show that the uptake of L-cystine
or L-glutamate was greater in Xenopus oocytes injected
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simultaneously with xCT and 4F2hc than in oocytes in-
jected with either xCT or 4F2hc alone. Preliminary ex-
periments in MDCK cells transfected with either xCT or
4F2hc suggest a similar trend.
Moreover, this study examined the ability of xCT to
function with rBAT, a heavy chain subunit localized ex-
clusively to the luminal plasma membrane of proximal
tubular cells. This subunit, also named NBAT or D2, in-
teracts normally with b0,+AT to form system b0,+ and pos-
sesses approximately 25% sequence identity with 4F2hc
[34]. Because of their homology and functional similari-
ties, these two subunits may be interchangeable with xCT
under certain conditions. Indeed, a previous in vitro study
using transiently transfected human retinal pigment ep-
ithelial cells and microinjected Xenopus oocytes, showed
that a b0,+AT-like protein is capable of functioning with
4F2hc, rather than rBAT [35]. Given this finding, it is
plausible to suggest that rBAT may interact with light
chains that normally associate with 4F2hc. Indeed, tran-
sient transfection of cultured NIH3T3 cells and microin-
jection of Xenopus oocytes with rBAT and xCT induced
transport activity like that of system x−c [36]. Similarly, our
data show that simultaneous injection of xCT and rBAT
into Xenopus oocytes, results in the ability of these cells
to take up L-cystine. Interestingly, unlike the aforemen-
tioned study, our data show that the uptake of L-cystine
by oocytes injected with xCT and rBAT was not inhibited
by L-glutamate, which is a competitive inhibitor of sys-
tem x−c . Thus, this uptake does not appear to be mediated
by system x−c . Alternatively, L-arginine, a competitive in-
hibitor of system b0,+, blocked the uptake of L-cystine
by 50%. Therefore, it appears that at least half of this
uptake is due to the activity of system b0,+, while the
transport system(s) responsible for the remaining frac-
tion is/are unknown. It should be pointed out that an
association between xCT, which is normally a basolateral
protein, and rBAT, which is localized in the luminal mem-
brane, has not been demonstrated in vivo. Yet, given the
current data, we can hypothesize that, within proximal
tubular cells, xCT may associate with rBAT, which may
consequently alter the membrane distribution of either
protein. As these two proteins distribute normally on
opposite plasma membranes, they may associate under
pathological conditions that result in a loss of cellular po-
larity. Our findings, therefore, may aid in explaining some
of the processes that occur when cells undergo pathologic
changes.
It is interesting to note that injection of Xenopus
oocytes with rBAT alone induced the uptake of L-cystine.
Similar to the findings of other studies [36], this uptake
was inhibited almost completely by the presence of L-
arginine, suggesting that rBAT can interact with endoge-
nous b0,+AT-like components in the oocytes to induce
system b0,+-like transport activity. One could argue that
the induction of L-cystine transport observed following
the simultaneous injection of xCT and rBAT may be due
solely to the expression of rBAT. Yet, the L-cystine trans-
port observed following the injection of these two sub-
units was significantly greater than that measured fol-
lowing the injection of rBAT alone. Clearly, additional
studies characterizing this uptake are necessary to un-
derstand fully this phenomenon.
Interestingly, it has been shown recently that system x−c
is capable of transporting substrates other than those that
have been traditionally associated with amino acid carri-
ers. Two studies in cultured rat glioma cells (LRM55) have
demonstrated that this carrier is capable of transporting
xenobiotics that may induce cellular intoxication [37, 38].
These studies emphasize the importance of a mammalian
model in which to study the activity of system x−c . Fur-
thermore, as the kidney participates in the excretion of
various toxic compounds, it is critical that the activity of
various carriers and their substrate specificities are un-
derstood. The cell model described in this study can be
used to provide a more complete understanding of the
transport activities in renal tubular cells.
CONCLUSION
Data from the present study indicate that L-cystine
and L-glutamate are high-affinity substrates for system
x−c (when expressed in MDCK cells transfected stably
with hxCT and h4F2hc). These data were validated by ex-
periments using Xenopus oocytes, and thus, indicate that
the xCT-4F2hc transfectants are reliable models for the
study of system x−c . The development of a mammalian cell
line in which system x−c is constitutively overexpressed is
novel and highly relevant to the field of amino acid trans-
port. To our knowledge, this study represents the first
report of a mammalian renal cell line transfected stably
with system x−c . This cell line can be used to further char-
acterize the activity of system x−c .
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